STOCK TITAN

Natera (NTRA) president John Fesko awarded 10,051 RSUs in stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Fesko John reported acquisition or exercise transactions in this Form 4 filing.

Natera, Inc. reported that President and Chief Business Officer John Fesko received a grant of 10,051 restricted stock units (RSUs) on common stock. These RSUs vest over four years, with 25% vesting on March 1, 2027 and the rest in 12 equal quarterly installments. After this award, Fesko holds 188,132 shares of common stock directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fesko John

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT, CHIEF BUS. OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 A 10,051(1) A (2) 188,132 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter.
2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
/s/ Tami Chen, Attorney-in-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Natera (NTRA) insider John Fesko report on this Form 4?

John Fesko reported receiving a grant of 10,051 restricted stock units in Natera common stock. This is an equity award, not an open-market purchase or sale, and reflects part of his compensation as President and Chief Business Officer.

How many Natera (NTRA) shares does John Fesko own after this transaction?

After the reported RSU grant, John Fesko beneficially owns 188,132 shares of Natera common stock directly. This total includes the impact of the 10,051 restricted stock units awarded in the transaction reported on this Form 4 filing.

How do the new Natera (NTRA) RSUs granted to John Fesko vest?

The 10,051 restricted stock units vest over four years. Twenty-five percent vest on March 1, 2027, and the remaining units vest in 12 equal quarterly installments thereafter, aligning the award with longer-term service at Natera.

What does each Natera (NTRA) RSU granted to John Fesko represent?

Each restricted stock unit granted to John Fesko represents a contingent right to receive one share of Natera’s common stock. The shares are delivered only as the RSUs vest according to the four-year vesting schedule described in the Form 4 footnotes.

Was there a purchase price for John Fesko’s Natera (NTRA) RSU grant?

The Form 4 shows a price per share of $0.0000 for the 10,051 restricted stock units. This indicates the RSUs were issued as a compensation award rather than acquired through an open-market purchase involving a cash payment by John Fesko.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

27.94B
133.30M
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN